[ Price : $8.95]
FDA rejects Otsuka Pharmaceutical and H. Lundbecks sNDA to expand the use of Rexulti (brexpiprazole) for treating post-traumatic s...[ Price : $8.95]
FDA takes two actions against autism by ordering a label change against acetaminophen (Tylenol) use in pregnancy approving leucovo...[ Price : $8.95]
FDA posts a final guidance outlining how the agency will decide when to temporarily allow use of unapproved diagnostic tests durin...[ Price : $8.95]
FDA grants accelerated approval to a Stealth Biotherapeutics NDA for Forzinity (elamipretide) injection for treating Barth syndrom...[ Price : $8.95]
FDA extends by three months its review of Sanofis multiple sclerosis drug tolebrutinib to evaluate additional analyses submitted r...[ Price : $8.95]
Roche reports positive Phase 3 data with its investigational breast cancer drug giredestrant.[ Price : $8.95]
FDA posts a draft guidance entitled Malaria: Developing Drugs for Treatment that outlines key considerations for companies develop...[ Price : $8.95]
Lexicon Pharmaceuticals says FDA is requiring additional time to review its new clinical data submitted earlier this month in an e...